If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

AI-assisted scoping review of code sharing in clinical prediction model research. Publication: Nature Medicine. Dana-Farber Cancer Institute authors: ...

An investigational antibody-drug conjugate demonstrated clinically meaningful and durable responses in patients with platinum-resistant ovarian cancer, including patients whose tumors had low or no ...

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

Rochelle G. Scheib, MD - Medical Oncology I absolutely love Dr. Scheib and am so very grateful she is my medical oncologist! She answers all of my & my husband's many questions in a clear, concise, ...

This research is being done to compare rates of hair loss of people with metastatic breast who use scalp cooling versus those who do not use scalp cooling after receiving standard of care treatment ...

Medical Director, Medical Oncology, Dana-Farber Brigham Cancer Center at South Shore Health ...

The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in a phase 1/2 first-in-human trial in patients with previously treated, RAS-mutant, metastatic pancreatic ...

A rare inherited mutation in the Epidermal Growth Factor Receptor (EGFR) gene is associated with a 25-fold increased risk of lung cancer, according to a study by investigators at Dana-Farber Cancer ...

Unintentional weight loss is associated with an increase in the risk of a cancer diagnosis within the coming year, according to a study from Dana-Farber Cancer Institute. Compared with participants ...

March 2021 Editor’s Note: For information about the COVID-19 vaccine for cancer patients. Defects linked to disruption of key protein involved in fetal development Finding will help guide development ...